Ernexa Therapeutics Inc. (ERNA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2022-11-14; 1-for-15, first reflected in a filing dated 2025-08-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

6.31M
Year ended 2025-12-31
17.59M2020-12-31: 17.59M2021-12-31: 2.17M2022-12-31: 3.05M2023-12-31: 5.31M2024-12-31: 910.0K2025-12-31: 6.31M6.31M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-316.31M+593.1%2026-03-13, From 2025-01-01
2024-12-31910.0Kn/c2026-03-13, From 2024-01-01
2023-12-315.31M+74.2%2025-03-12, From 2023-01-01
2022-12-313.05M+40.9%2024-03-14, From 2022-01-01
2021-12-312.17Mn/c2023-03-20, From 2021-01-01
2020-12-3117.59Mn/a2022-07-01, From 2020-01-01